全文获取类型
收费全文 | 303篇 |
免费 | 21篇 |
出版年
2021年 | 8篇 |
2019年 | 4篇 |
2018年 | 3篇 |
2017年 | 3篇 |
2016年 | 6篇 |
2015年 | 13篇 |
2014年 | 7篇 |
2013年 | 21篇 |
2012年 | 17篇 |
2011年 | 12篇 |
2010年 | 8篇 |
2009年 | 7篇 |
2008年 | 13篇 |
2007年 | 11篇 |
2006年 | 8篇 |
2005年 | 9篇 |
2004年 | 12篇 |
2003年 | 9篇 |
2002年 | 9篇 |
2001年 | 6篇 |
2000年 | 10篇 |
1999年 | 5篇 |
1998年 | 10篇 |
1997年 | 3篇 |
1994年 | 5篇 |
1993年 | 2篇 |
1992年 | 4篇 |
1991年 | 2篇 |
1990年 | 6篇 |
1989年 | 4篇 |
1988年 | 4篇 |
1987年 | 4篇 |
1986年 | 4篇 |
1985年 | 6篇 |
1984年 | 2篇 |
1983年 | 3篇 |
1982年 | 5篇 |
1981年 | 2篇 |
1980年 | 2篇 |
1979年 | 2篇 |
1978年 | 2篇 |
1975年 | 4篇 |
1972年 | 3篇 |
1971年 | 2篇 |
1970年 | 4篇 |
1969年 | 4篇 |
1967年 | 6篇 |
1966年 | 3篇 |
1961年 | 2篇 |
1957年 | 2篇 |
排序方式: 共有324条查询结果,搜索用时 31 毫秒
31.
32.
Chen YT Alpen B Ono T Gure AO Scanlan MA Biggs WH Arden K Nakayama E Old LJ 《Genomics》2003,82(6):628-636
Human SSX was first identified as the gene involved in the t(X;18) translocation in synovial sarcoma. SSX is a multigene family, with 9 complete genes on chromosome Xp11. Normally expressed almost exclusively in testis, SSX mRNA is expressed in various human tumors, defining SSX as a cancer/testis antigen. We have now cloned the mouse ortholog of SSX. Mouse SSX genes can be divided into Ssxa and Ssxb subfamilies based on sequence homology. Ssxa has only one member, whereas 12 Ssxb genes, Ssxb1 to Ssxb12, were identified by cDNA cloning from mouse testis and mouse tumors. Both Ssxa and Ssxb are located on chromosome X and show tissue-restricted mRNA expression to testis among normal tissues. All putative human and mouse SSX proteins share conserved KRAB and SSX-RD domains. Mouse tumors were found to express some, but not all, Ssxb genes, similar to the SSX activation in human tumors. 相似文献
33.
Takahashi M Rapley E Biggs PJ Lakhani SR Cooke D Hansen J Blair E Hofmann B Siebert R Turner G Evans DG Schrander-Stumpel C Beemer FA van Vloten WA Breuning MH van den Ouweland A Halley D Delpech B Cleveland M Leigh I Chapman P Burn J Hohl D Görög JP Seal S Mangion J 《Human genetics》2000,106(1):58-65
Familial cylindromatosis is an autosomal dominant predisposition to multiple neoplasms of the skin appendages. The susceptibility gene has previously been mapped to chromosome 16q12-q13 and has features of a recessive oncogene/tumour suppressor gene. We have now evaluated 19 families with this disease by a combination of genetic linkage analysis and loss of heterozygosity in cylindromas from affected individuals. All 15 informative families show linkage to this locus, providing no evidence for genetic heterogeneity. Recombinant mapping has placed the gene in an interval of approximately 1 Mb. There is no evidence, between families, of haplotype sharing that might be indicative of common founder mutations. 相似文献
34.
35.
Nicki Biggs 《Curtis's Botanical Magazine》2004,21(3):193-196
Summary. A miniature gesneriad, Sinningia pusilla(C. Mart.) Baill. from Brazil is described and illustrated, and notes are given on the horticultural history of the genus Sinningia 相似文献
36.
37.
Van B. Lu S. Balasubramanyan J. E. Biggs M. J. Stebbing S. L. Gustafson K. Todd A. Lai D. Dawbarn W. F. Colmers K. Ballanyi P. A. Smith 《Neurophysiology》2007,39(4-5):272-283
Chronic constriction injury (CCI) of the rat sciatic nerve increases the dorsal horn excitability. This “central sensitization”
leads to behavioral manifestations analogous to those related to human neuropathic pain. We found, using whole-cell recording
from acutely isolated spinal cord slices, that 7-to 10-day-long CCI increases excitatory synaptic drive to putative excitatory
“delay”-firing neurons in the substantia gelatinosa but attenuates that to putative inhibitory “tonic”-firing neurons. A defined-medium organotypic culture (DMOTC) system was
used to investigate the long-term actions of brain-derived neurotrophic factor (BDNF) as a possible instigator of these changes.
When all five neuronal types found in the substantia gelatinosa were considered, BDNF and CCI produced similar patterns, or “footprints,” of changes across the whole population. This pattern
was not seen with another putative “pain mediator,” interleukin 1β. Thus, BDNF decreased synaptic drive to “tonic” neurons
and increased synaptic drive to “delay” neurons. Actions of BDNF on “delay” neurons were presynaptic and involved increased
mEPSC frequency and amplitude without changes in the function of postsynaptic AMPA receptors. By contrast, BDNF exerted both
pre-and post-synaptic actions on “ tonic” cells to reduce the mEPSC frequency and amplitude. These differential actions of
BDNF on excitatory and inhibitory neurons contributed to a global increase in the dorsal horn network excitability as assessed
by the amplitude of depolarization-induced increases in the intracellular [Ca2+]. Experiments with the BDNF-binding protein TrkB-d5 provided additional evidence for BDNF as a harbinger of neuropathic pain.
Thus, the cellular processes altered by BDNF likely contribute to “central sensitization” and hence to the onset of neuropathic
pain.
Neirofiziologiya/Neurophysiology, Vol. 39, Nos. 4/5, pp. 315–326, July–October, 2007. 相似文献
38.
39.
40.
Biggs T Foreman J Sundstrom L Regenass U Lehembre F 《Journal of biomolecular screening》2011,16(8):805-817
Glioblastoma multiforme (GBM) is the most common and most aggressive type of primary brain tumor. Identification of new therapeutic regimens is urgently needed. A major challenge remains the development of a relevant in vitro model system with the necessary capacity and flexibility to profile compounds. The authors have developed and characterized a 3D culture system of brain cells (brain Hi-Spot) where GBM-derived cells can be incorporated (GBM/brain Hi-Spot). Immuno-fluorescence and electrophysiological recordings demonstrate that brain Hi-Spots recapitulate many features of brain tissue. Within this tissue, GBM-derived cell growth is monitored using a fluorescence assay. GBM-derived cells growing in Hi-Spots form tumor nodules that display properties of GBM such as 5-Ala positive staining, an acidic environment, and tumor-surrounding astrocyte activation. Temozolomide inhibits GBM growth in brain Hi-Spots, but it is not effective in 2D cultures. Other chemotherapeutics that have proven to be inefficient in GBM treatment display low activity against GBM-derived cells growing in brain Hi-Spots in comparison to their activity against GBM 2D cultures. These findings suggest that GBM/brain Hi-Spots represent a simple system to culture cells derived from brain tumors in an orthotopic environment in vitro and that the system is reliable to test GBM targeting compounds. 相似文献